Experts to Share Extensive Experience From Pivitol Immunocology Clinical Studies

/EINPresswire.com/ -- TORONTO, ON--(Marketwired - October 27, 2015) - Explore the growing field of immuno-oncology, including the competitive landscape and best practices for the clinical development of immunotherapies, during a webinar hosted by Xtalks.

Recent advances in immuno-oncology, including the launch of immune checkpoint inhibitors, have demonstrated the potential to greatly improve treatment outcomes for patients with hard-to-treat diseases, such as metastatic melanoma and non-small cell lung cancer. However, the evolving landscape can pose unique challenges for biopharmaceutical sponsors.

Experts from inVentiv Health will explore the obstacles and nuances of this rapidly growing field during a free, one-hour webinar on November 4 beginning at 11 am EST / 4 pm GMT (UK) / 5 pm CET (EU-Central). inVentiv Health, a top-tier professional services organization, has supported about 80 percent of all oncology drugs approved by the FDA in recent years. In the area of advanced oncology therapies, they have worked on clinical programs and commercialization for all immuno-onocolgy products approved by the FDA.

This webinar will summarize key aspects of evaluating safety and efficacy in studies of immune checkpoint inhibitors, as well as describe operational strategies that support successful trial execution and regulatory approval. The panel will also present medical and operational lessons learned from past immuno-oncology trials, along with an assessment of the current pipeline of immunotherapy agents and the coming market trends.

Hear insights and discuss your questions with the panelists, including:

• Thomas Moehler, MD, Ph.D., Vice President, Medical and Scientific Affairs, Hematology/Oncology, inVentiv Health
• Cheryl Askew, Ph.D., Senior Director, Program Delivery, Hematology/Oncology, inVentiv Health
• Jessica Lee, Ph.D., Senior Engagement Manager, Campbell Alliance, an inVentiv Health Company

The webinar's key learning objectives are to:

• Understand key aspects of evaluating immuno-oncology trials
• Learn best practices in medical management of immune-related AE management and response criteria
• Identify considerations for operational planning and execution on immunotherapy clinical trials
• Learn about the competitive landscape and implications for the commercialization of immunotherapy assets

To learn more or register for this event visit: Immuno-Oncology Clinical Trials

Best Practices for Clinical Development of Immunotherapies.

About inVentiv Health

inVentiv Health is a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) help clients improve their performance to deliver much-needed therapies to market. With 14,000 employees providing services to clients in 70 countries, inVentiv Health designs best practices, processes and systems to enable clients to successfully navigate an increasingly complex environment. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv Health management team. For more information, visit inVentivHealth.com.

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, health care centers, etc.) turn to Xtalks for access to quality content. Xtalks helps life science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/sponsorship.ashx.

Image Available: http://www.marketwire.com/library/MwGo/2015/10/26/11G069029/Images/inVentivHealth_rgb-280646358745.jpg

Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.